- Do you own shares of Cubist Pharmaceuticals, Inc. (NASDAQ GS: CBST)?
- Did you purchase any of your shares prior to December 8, 2014?
- Do you think the proposed buyout price is too low?
- Do you want to discuss your rights?
Please contact Rigrodsky & Long, P.A. (“R & L”) to schedule a free consultation. You may call us or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.
R & L is investigating potential claims against the board of directors of Cubist Pharmaceuticals, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to be acquired by Merck & Co., Inc. for $102.00, or approximately $9.5 billion.